Hepion Pharmaceuticals, Inc
Hepion Pharmaceuticals is a clinical stage biopharmaceutical company based in Edison, NJ, specializing in the development of AI-driven therapeutic drugs for the treatment of chronic liver diseases such as non-alcoholic steatohepatitis (NASH), fibrotic diseases, hepatocellular carcinoma (HCC), and other related conditions.
The company's lead drug candidate, rencofilstat, is a potent inhibitor of cyclophilins, which play a crucial role in various disease processes. Rencofilstat has demonstrated promising results in reducing liver fibrosis and hepatocellular carcinoma tumor burden in preclinical models and is currently undergoing Phase 2 clinical development for NASH treatment.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.